User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

The RESPECT study: RESearch on the PrEvalence and the diagnosis of COPD and its Tobacco-related etiology: a study protocol.

  1. The Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2015 [ http://www.goldcopd.org ]
  2. Shmelev E.I: Chronic obstructive pulmonary disease. In Respiratory medicine. Guidelines, Volume 1. Edited by Chuchalin A.G. Moscow 2007, 597-601. [In Russian.] Шмелев Е.И. Хроническая обструктивная болезнь легких. Респираторная медицина: Руководство, Том 1. Под ред. А.Г. Чучалина. Москва, 2007, 597—601.
  3. Sinopalnikov AI, Vorobiev AV. Epidemiology of COPD: state of the art of an actual problem. Pulmonology. 2007;6:78–86. [In Russian.] Синопальников А.И., Воробьев А.В. Эпидемиология ХОБЛ. Современное состояние актуальной проблемы. Пульмонология 2007, 6:78-86.
  4. COPD Russian Federal program 2004 [ http://www.pulmonology.ru/about/gard/COPD_federal_program_2004.pdf ]
  5. Zhestkov AV, Kosarev VV, Babanov SA, Glazitov AV. The epidemiology and risk factors of chronic obstructive pulmonary disease in a large industrial center of the Middle Volga River Region. Prevention and health promotion. 2009;1:42–4. [In Russian]. Жестков А.В., Косарев В.В., Бабанов С.А., Глазитов А.В. Эпидемиология и факторы риска хронической обструктивной болезни легких в крупном промышленном центре Среднего Поволжья. Профилактика заболеваний и укрепление здоровья 2009, 1:42-44.
  6. Krasnova YN, Grimailova EV, Dzizinsky AA, Cherniak BA. Prevalence of chronic obstructive pulmonary disease in Irkutsk region. Pulmonology. 2006;1:98–102. [In Russian.] Краснова Ю.Н., Гримайлова Е.В., Дзизинский А.А., Черняк Б.А. Распространенность хронической обструктивной болезни легких в Иркутской области. Пульмонология 2006, 1:98-102.
  7. Global Adult Tobacco Survey (GATS): Russian Federation 2009. Country report: [ http://www.who.int/tobacco/surveillance/en_tfi_gats_russian_countryreport.pdf ]
  8. Doney Brent, Hnizdo Eva, Graziani Monica, Kullman Greg, Burchfiel Cecil, Baron Sherry, Fujishiro Kaori, Enright Paul, Hankinson John L., Stukovsky Karen Hinckley, Martin Christopher J., Donohue Kathleen M., Barr R. Graham, Occupational Risk Factors for COPD Phenotypes in the Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study, 10.3109/15412555.2013.813448
  9. Ferkol Thomas, Schraufnagel Dean, The Global Burden of Respiratory Disease, 10.1513/annalsats.201311-405ps
  10. Miller A., Of Dung and Dynein Arms: Understanding COPD in Nonsmokers, 10.4187/respcare.02334
  11. Martinez Carlos H., Han MeiLan K., Contribution of the Environment and Comorbidities to Chronic Obstructive Pulmonary Disease Phenotypes, 10.1016/j.mcna.2012.02.007
  12. Price David B., Tinkelman David G., Halbert R.J., Nordyke Robert J., Isonaka Sharon, Nonikov Dmitry, Juniper Elizabeth F., Freeman Daryl, Hausen Thomas, Levy Mark L., Østrem Anders, van der Molen Thys, van Schayck Constant P., Symptom-Based Questionnaire for Identifying COPD in Smokers, 10.1159/000090142
  13. Price David B., Tinkelman David G., Nordyke Robert J., Isonaka Sharon, Halbert R.J., Scoring System and Clinical Application of COPD Diagnostic Questionnaires, 10.1378/chest.129.6.1531
  14. Kotz D., Nelemans P., van Schayck C. P., Wesseling G. J., External validation of a COPD diagnostic questionnaire, 10.1183/09031936.00074307
  15. Broekhuizen B. D., Sachs A. P., Oostvogels R., Hoes A. W, Verheij T. J., Moons K. G., The diagnostic value of history and physical examination for COPD in suspected or known cases: a systematic review, 10.1093/fampra/cmp026
  16. COPD assessment test [ http://www.catestonline.co.uk ]
  17. Fletcher C. M., Elmes P. C., Fairbairn A. S., Wood C. H., Significance of Respiratory Symptoms and the Diagnosis of Chronic Bronchitis in a Working Population, 10.1136/bmj.2.5147.257
  18. Degryse J., Buffels J., Van Dijck Y., Decramer M., Nemery B., Accuracy of Office Spirometry Performed by Trained Primary-Care Physicians Using the MIR Spirobank Hand-Held Spirometer, 10.1159/000334907
  19. Miller Martin R., Quanjer Philip H., Swanney Maureen P., Ruppel Gregg, Enright Paul L., Interpreting Lung Function Data Using 80% Predicted and Fixed Thresholds Misclassifies More Than 20% of Patients, 10.1378/chest.10-0189
  20. Swanney M P, Ruppel G, Enright P L, Pedersen O F, Crapo R O, Miller M R, Jensen R L, Falaschetti E, Schouten J P, Hankinson J L, Stocks J, Quanjer P H, Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction, 10.1136/thx.2008.098483
  21. Quanjer Philip H., Stanojevic Sanja, Cole Tim J., Baur Xaver, Hall Graham L., Culver Bruce H., Enright Paul L., Hankinson John L., Ip Mary S.M., Zheng Jinping, Stocks Janet, , Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations, 10.1183/09031936.00080312
  22. Global Lung Function Initiative [ http://www.lungfunction.org ]
  23. Gessner C, Wirts H. Interleukins and other proteins. Eur Respir Mon. 2010;49:217–30.
  24. Cazzola Mario, Novelli Giuseppe, Biomarkers in COPD, 10.1016/j.pupt.2010.05.001
  25. Agustí Alvar, Edwards Lisa D., Rennard Stephen I., MacNee William, Tal-Singer Ruth, Miller Bruce E., Vestbo Jørgen, Lomas David A., Calverley Peter M. A., Wouters Emiel, Crim Courtney, Yates Julie C., Silverman Edwin K., Coxson Harvey O., Bakke Per, Mayer Ruth J., Celli Bartolome, , Persistent Systemic Inflammation is Associated with Poor Clinical Outcomes in COPD: A Novel Phenotype, 10.1371/journal.pone.0037483
  26. Wouters E. F. M., Groenewegen K. H., Dentener M. A., Vernooy J. H. J., Systemic Inflammation in Chronic Obstructive Pulmonary Disease: The Role of Exacerbations, 10.1513/pats.200706-071th
  27. European Respiratory Society. Management of chronic obstructive pulmonary disease. In: European Respiratory Society Monograph, vol. 38. 2006. p. 478.
  28. Bakke P. S., Ronmark E., Eagan T., Pistelli F., Annesi-Maesano I., Maly M., Meren M., Vermeire  P., Vestbo J., Viegi G., Zielinski J., Lundback B., Recommendations for epidemiological studies on COPD, 10.1183/09031936.00193809
  29. The official website of the St. Petersburg Administration [ http://gov.spb.ru/helper/day/people/ ]
  30. The official site of the Government of the Arkhangelsk region [ http://www.dvinaland.ru/region/mo/arkhangelsk.php ]
  31. Daniel WW, Cross CL. Biostatistics: Basic Concepts and Methodology for the Health Sciences. 10th ed. New York: John Wiley & Sons; 2013.
  32. WiPaM telemedicine platform [ http://www.ixsys.eu/home.html ]
  33. Cockerham William C., Health lifestyles and the absence of the Russian middle class : Health lifestyles and middle class in Russia, 10.1111/j.1467-9566.2007.00492.x
  34. Eisner Mark D., Katz Patricia P., Yelin Edward H., Hammond S. Katharine, Blanc Paul D., Measurement of Environmental Tobacco Smoke Exposure among Adults with Asthma, 10.1289/ehp.01109809
  35. Eisner Mark D, Balmes John, Katz Patricia P, Trupin Laura, Yelin Edward H, Blanc Paul D, Lifetime environmental tobacco smoke exposure and the risk of chronic obstructive pulmonary disease, 10.1186/1476-069x-4-7
  36. American Thoracic Society 1978 Adult Questionnaire ATS-DLD-78 recommended adult questionnaire [ http://www.cdc.gov/niosh/respire.html ]
  37. Eisner M D, Exposure to indoor combustion and adult asthma outcomes: environmental tobacco smoke, gas stoves, and woodsmoke, 10.1136/thorax.57.11.973
  38. Bridevaux P.-O., Probst-Hensch N. M., Schindler C., Curjuric I., Felber Dietrich D., Braendli O., Brutsche M., Burdet L., Frey M., Gerbase M. W., Ackermann-Liebrich U., Pons M., Tschopp J.-M., Rochat T., Russi E. W., Prevalence of airflow obstruction in smokers and never-smokers in Switzerland, 10.1183/09031936.00004110
  39. Tinkelman David G., Price David B., Nordyke Robert J., Halbert R.J., Isonaka Sharon, Nonikov Dmitry, Juniper Elizabeth F., Freeman Daryl, Hausen Thomas, Levy Mark L., Østrem Anders, van der Molen Thys, van Schayck Constant P., Symptom-Based Questionnaire for Differentiating COPD and Asthma, 10.1159/000090141
  40. Levy Mark L., Fletcher Monica, Price David B., Hausend Thomas, Halbert Ron J., Yawn Barbara P., International Primary Care Respiratory Group (IPCRG) Guidelines: Diagnosis of respiratory diseases in primary care, 10.1016/j.pcrj.2005.10.004
  41. Pokhaznikova M A, Kuznetsova O Yu, Andreeva E A, Moiseeva I E, Lebedev A K, EXPERIENCE OF DEVELOPMENT OF DISTANCE LEARNING COURSE OF SPIROMETRY IN TRAINING OF GENERAL PRACTITIONERS, 10.17816/rfd2012439-44
  42. Distant learning course of spirometry [In Russian] http://www.spirocourse.ru/
  43. Pérez-Padilla R, Vázquez-García JC, Márquez MN, Jardim JR, Pertuzé J, Lisboa C, et al. Latin american COPD prevalence study (PLATINO) team: the long-term stability of portable spirometers used in a multinational study of the prevalence of chronic obstructive pulmonary disease. Respir Care. 2006;51(10):1167–71.
  44. Miller M. R., Standardisation of spirometry, 10.1183/09031936.05.00034805
  45. Schneeweiss Sebastian, Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics, 10.1002/pds.1200
  46. Thabane Lehana, Mbuagbaw Lawrence, Zhang Shiyuan, Samaan Zainab, Marcucci Maura, Ye Chenglin, Thabane Marroon, Giangregorio Lora, Dennis Brittany, Kosa Daisy, Debono Victoria Borg, Dillenburg Rejane, Fruci Vincent, Bawor Monica, Lee Juneyoung, Wells George, Goldsmith Charles H, A tutorial on sensitivity analyses in clinical trials: the what, why, when and how, 10.1186/1471-2288-13-92
  47. Rosenbaum PR. Sensitivity Analysis in Observational Studies. In: Everitt BS, Howel DC, editors. Encyclopedia of Statistics in Behavioral Science, vol. 4. Chichester: ohn Wiley & Sons, Ltd; 2005. p. 1809–14.
  48. Zigmond A. S., Snaith R. P., The Hospital Anxiety and Depression Scale, 10.1111/j.1600-0447.1983.tb09716.x
  49. FRAX Fracture Risk Assessment Tool [ http://www.shef.ac.uk/FRAX/tool.aspx?country=13 ]
  50. EuroQol - a new facility for the measurement of health-related quality of life, 10.1016/0168-8510(90)90421-9
  51. EQ-5D [ http://www.euroqol.org/about-eq-5d/how-to-use-eq-5d.html ]
  52. Peters Michele, Crocker Helen, Jenkinson Crispin, Doll Helen, Fitzpatrick Ray, The routine collection of patient-reported outcome measures (PROMs) for long-term conditions in primary care: a cohort survey, 10.1136/bmjopen-2013-003968
  53. Jones P. W., Harding G., Berry P., Wiklund I., Chen W-H., Kline Leidy N., Development and first validation of the COPD Assessment Test, 10.1183/09031936.00102509
  54. The STROBE Statement (STrengthening the Reporting of OBservational studies in Epidemiology) [ http://www.strobe-statement.org ]
  55. The Russian Population Census 2010 [ http://www.gks.ru/free_doc/new_site/perepis2010/croc/perepis_itogi1612.htm ]
  56. Halbert R. J., Natoli J. L., Gano A., Badamgarav E., Buist A. S., Mannino D. M., Global burden of COPD: systematic review and meta-analysis, 10.1183/09031936.06.00124605
  57. Buist A Sonia, McBurnie Mary Ann, Vollmer William M, Gillespie Suzanne, Burney Peter, Mannino David M, Menezes Ana MB, Sullivan Sean D, Lee Todd A, Weiss Kevin B, Jensen Robert L, Marks Guy B, Gulsvik Amund, Nizankowska-Mogilnicka Ewa, International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study, 10.1016/s0140-6736(07)61377-4
  58. Voinov AY, Lobanov AA. Epidemiology of chronic obstructive pulmonary diseases. Med Tr Prom Ekol. 2003;4:23–5. [In Russian]. Воинов А. Ю., Лобанов А. А.: Эпидемиология хронических обструктивных заболеваний легких Медицина труда и промышленная экология, 2003; 4 :23-25.
  59. Chuchalin Alexander, Khaltaev Nikolai, Antonov Nikolay, Galkin Dmitry, Manakov Leonid, Antonini Paola, Murphy Michael, Solodovnikov Alexander, Bousquet Jean, Pereira Marcelo, Demko Irina, Chronic respiratory diseases and risk factors in 12 regions of the Russian Federation, 10.2147/copd.s67283
  60. Rennard Stephen I., Vestbo Jørgen, Agustí Alvar, What Is Chronic Obstructive Pulmonary Disease Anyway?. Continua, Categories, Cut Points, and Moving beyond Spirometry, 10.1164/rccm.201212-2321ed
  61. Holleman Donald R., Does the Clinical Examination Predict Airflow Limitation?, 10.1001/jama.1995.03520280059041
  62. Straus Sharon E., The Accuracy of Patient History, Wheezing, and Laryngeal Measurements in Diagnosing Obstructive Airway Disease, 10.1001/jama.283.14.1853
  63. Pauwels Romain, COPD, 10.1378/chest.117.5_suppl_2.332s
  64. Halbert R.J., Isonaka Sharon, George Dorothy, Iqbal Ahmar, Interpreting COPD Prevalence Estimates, 10.1378/chest.123.5.1684
  65. Stanley Anthony J, Hasan Iqbal, Crockett Alan J, van Schayck Onno CP, Zwar Nicholas A, Validation of the COPD Diagnostic Questionnaire in an Australian general practice cohort: a cross-sectional study, 10.4104/pcrj.2014.00015
  66. VAN SCHAYCK Constant P., HALBERT Ronald J., NORDYKE Robert J., ISONAKA Sharon, MARONI Jaman, NONIKOV Dmitry, Comparison of existing symptom-based questionnaires for identifying COPD in the general practice setting, 10.1111/j.1440-1843.2005.00720.x
  67. Celli B.R., MacNee W., Agusti A., Anzueto A., Berg B., Buist A.S., Calverley P.M.A., Chavannes N., Dillard T., Fahy B., Fein A., Heffner J., Lareau S., Meek P., Martinez F., McNicholas W., Muris J., Austegard E., Pauwels R., Rennard S., Rossi A., Siafakas N., Tiep B., Vestbo J., Wouters E., ZuWallack R., Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper, 10.1183/09031936.04.00014304
  68. Pellegrino R., Interpretative strategies for lung function tests, 10.1183/09031936.05.00035205
  69. Szanto Orsolya, Montnemery Peter, Elmstahl Solve, Prevalence of airway obstruction in the elderly: results from a cross-sectional spirometric study of nine age cohorts between the ages of 60 and 93 years, 10.4104/pcrj.2010.00011
  70. Stanojevic Sanja, Wade Angie, Stocks Janet, Hankinson John, Coates Allan L., Pan Huiqi, Rosenthal Mark, Corey Mary, Lebecque Patrick, Cole Tim J., Reference Ranges for Spirometry Across All Ages : A New Approach, 10.1164/rccm.200708-1248oc
  71. Stanojevic S., Wade A., Stocks J., Reference values for lung function: past, present and future, 10.1183/09031936.00143209
  72. Vaz Fragoso Carlos A., Concato John, McAvay Gail, Van Ness Peter H., Rochester Carolyn L., Yaggi H. Klar, Gill Thomas M., The Ratio of FEV1to FVC as a Basis for Establishing Chronic Obstructive Pulmonary Disease, 10.1164/rccm.200909-1366oc
  73. Stang Paul, Lydick Eva, Silberman Cheryl, Kempel Angela, Keating Elizabeth T., The Prevalence of COPD, 10.1378/chest.117.5_suppl_2.354s
  74. Quanjer PH. Correctly defining criteria for diagnosing chronic obstructive pulmonary disease matters. Am J Respir Crit Care Med. 2014;189(2):230.
  75. Carolan Brendan J., Sutherland E. Rand, Clinical phenotypes of chronic obstructive pulmonary disease and asthma: Recent advances, 10.1016/j.jaci.2013.01.010
  76. Lamprecht Bernd, McBurnie Mary Ann, Vollmer William M., Gudmundsson Gunnar, Welte Tobias, Nizankowska-Mogilnicka Ewa, Studnicka Michael, Bateman Eric, Anto Josep M., Burney Peter, Mannino David M., Buist Sonia A., COPD in Never Smokers, 10.1378/chest.10-1253
  77. Brusselle Guy G, Joos Guy F, Bracke Ken R, New insights into the immunology of chronic obstructive pulmonary disease, 10.1016/s0140-6736(11)60988-4
Bibliographic reference Andreeva, Elena ; Pokhaznikova, Marina ; Lebedev, Anatoly ; Moiseeva, Irina ; Kozlov, Anton ; et. al. The RESPECT study: RESearch on the PrEvalence and the diagnosis of COPD and its Tobacco-related etiology: a study protocol.. In: BMC Public Health, Vol. 15, no.1, p. 831 (2015)
Permanent URL http://hdl.handle.net/2078.1/165023